Johnson & Johnson Begins Phase 3 COVID-19 Vaccine Trials

Watch VideoA single-shot coronavirus vaccine has entered the final stages of testing.

Johnson & Johnson says it's beginning a 60,000-person clinical trial on three continents. Participants will receive a single vaccine dose or a placebo.

It's made with slightly different technology than others in late-stage testing. Johnson...